John R. Desjarlais - Nov 11, 2024 Form 4 Insider Report for Xencor Inc (XNCR)

Role
SR. VICE PRESIDENT & CSO
Signature
/s/ Celia E. Eckert, Attorney-in-Fact
Stock symbol
XNCR
Transactions as of
Nov 11, 2024
Transactions value $
-$334,562
Form type
4
Date filed
11/13/2024, 05:46 PM
Previous filing
Jul 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XNCR Common Stock Options Exercise $1.08M +68.7K +34.32% $15.69 269K Nov 11, 2024 Direct F1
transaction XNCR Common Stock Sale -$1.61M -68.7K -25.55% $23.48 200K Nov 11, 2024 Direct F1, F2, F3
transaction XNCR Common Stock Options Exercise $200K +12.8K +6.38% $15.69 213K Nov 12, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XNCR Stock Option (Right to Buy) Options Exercise $0 -68.7K -80.8% $0.00 16.3K Nov 11, 2024 Common Stock 68.7K $15.69 Direct F1, F4
transaction XNCR Stock Option (Right to Buy) Options Exercise $0 -12.8K -78.29% $0.00 3.54K Nov 12, 2024 Common Stock 12.8K $15.69 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person on June 14, 2024.
F2 Represents the disposition of shares sold to pay option cost and estimated tax liability due upon option exercise.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.25 to $24.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F4 25% of the shares subject to the option vested on the one year anniversary of February 12, 2015 (the "Vesting Commencement Date"), and 1/48th of the shares vested monthly thereafter, such that the option was fully vested and exercisable on the four year anniversary of the Vesting Commencement Date.